Neutrophil-Lymphocyte Ratio in Locally Recurrent Nasopharyngeal Carcinoma Patients Treated With Intensity-Modulated Carbon-Ion Radiation Therapy Versus Intensity-Modulated Radiation Therapy

MLA

Jiade Lu, et al. “Neutrophil-Lymphocyte Ratio in Locally Recurrent Nasopharyngeal Carcinoma Patients Treated With Intensity-Modulated Carbon-Ion Radiation Therapy Versus Intensity-Modulated Radiation Therapy.” International Journal of Radiation Oncology*Biology*Physics, vol. 99, Oct. 2017, pp. E348–49. EBSCOhost, https://doi.org/10.1016/j.ijrobp.2017.06.1434.

APA

Jiade Lu, Ling-Qun Kong, Chunchun Hu, S.Z. Wang, & Jiyi Hu. (2017). Neutrophil-Lymphocyte Ratio in Locally Recurrent Nasopharyngeal Carcinoma Patients Treated With Intensity-Modulated Carbon-Ion Radiation Therapy Versus Intensity-Modulated Radiation Therapy. International Journal of Radiation Oncology*Biology*Physics, 99, E348–E349. https://doi.org/10.1016/j.ijrobp.2017.06.1434

Chicago

Jiade Lu, Ling-Qun Kong, Chunchun Hu, S.Z. Wang, and Jiyi Hu. 2017. “Neutrophil-Lymphocyte Ratio in Locally Recurrent Nasopharyngeal Carcinoma Patients Treated With Intensity-Modulated Carbon-Ion Radiation Therapy Versus Intensity-Modulated Radiation Therapy.” International Journal of Radiation Oncology*Biology*Physics 99 (October): E348–49. doi:10.1016/j.ijrobp.2017.06.1434.